Account
Inquiry
XCE Tirzepatide (LY3298176) represents a significant advancement in peptide research, particularly for metabolic studies. This synthetic peptide analog demonstrates dual GIP and GLP-1 receptor agonist activity, making it valuable for diabetes and obesity-related research applications.
Our pharmaceutical grade XCE Tirzepatide is produced under strict quality control measures to ensure batch-to-batch consistency. The lyophilized powder form ensures optimal stability and reconstitution properties for laboratory use.
Key research applications include: investigation of glucose-dependent insulin secretion mechanisms, studies on gastric emptying regulation, and exploration of potential weight management effects through central nervous system pathways.
The product is supplied in sterile vials with rubber stoppers and aluminum seals to maintain purity. Each batch undergoes comprehensive analytical testing including HPLC, mass spectrometry, and amino acid analysis to verify identity and purity.
Storage recommendations: Maintain lyophilized powder at -20°C in desiccated conditions. After reconstitution, store at 2-8°C for short-term use or aliquot and freeze at -80°C for long-term preservation.
This product is intended for research use only by qualified professionals in laboratory settings. Not for human consumption or diagnostic use.
